To investigate resistance-associated substitutions (RASs) as well as retreatment efficacies in a large cohort of European patients with failure of glecaprevir/pibrentasvir.
de Salazar, A., Dietz, J., di Maio, V.c., Vermehren, J., Paolucci, S., Müllhaupt, B., et al. (2020). Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75(11), 3349-3358 [10.1093/jac/dkaa304].
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen
di Maio, Velia Chiara;Ceccherini-Silberstein, Francesca
2020-11-01
Abstract
To investigate resistance-associated substitutions (RASs) as well as retreatment efficacies in a large cohort of European patients with failure of glecaprevir/pibrentasvir.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
dkaa304.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
389.85 kB
Formato
Adobe PDF
|
389.85 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.